Live feed
Filing
SC 13G
SC 13G0001897612-24-001393·PRICE T ROWE ASSOCIATES INC /MD/
Schedule 13G ownership disclosure
Tenax Therapeutics, Inc.
Security class unavailable · CUSIP: 88032L605
Event date: 2024-08-31
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 3,750,000
- Percent of class
- 19.9900%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001897612-24-001393
- Form type
- SC 13G
- Filer
- PRICE T ROWE ASSOCIATES INC /MD/
- CIK
- CIK 80255
- Filed
- Sep 10, 2024
- Reporting period
- Aug 31, 2024
- Description
- Schedule 13G beneficial ownership